Clinical Trial Update: Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describing Endostar (recombinant human endostatin) given with chemotherapy for advanced lung adenocarcinoma; the current trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Endostar (recombinant human endostatin)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Adenocarcinoma of Lung | Phase 4 | Status: UNKNOWN